1-17 of 17
Paul Moss
Close
Sort by
Articles

CAR-T Comes to the Rescue: Cell Therapy Makes 2018 Headlines in the Management of Relapsed Large B-cell Lymphoma

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 16 (1)
https://doi.org/10.1182/hem.V16.1.9289
Published: 2018
Articles

Mimicry Not Replacement: Molecular Engineering Transforms the Outlook in Hemophilia A

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (6)
https://doi.org/10.1182/hem.V15.6.9049
Published: 2018
Articles

Shedding Light on Migration of the Hematopoietic Niche Into Bone

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (5)
https://doi.org/10.1182/hem.V15.5.8920
Published: 2018
Articles

Genetic Correction of Thalassemia: Development of a Transformative Is Delivered

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (4)
https://doi.org/10.1182/hem.V15.4.8755
Published: 2018
Articles

Together Not Apart: Combining Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (3)
https://doi.org/10.1182/hem.V15.3.8483
Published: 2018
Articles

Deconstructing the Threat of the Fava Bean

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (2)
https://doi.org/10.1182/hem.V15.2.8304
Published: 2018
Articles

Venetoclax: Shaking CLL Off the Tree

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2018) 15 (1)
https://doi.org/10.1182/hem.V15.1.8178
Published: 2018
Articles

Ask the Hematologist: Getting CAR-T onto the Road

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2017) 14 (5)
https://doi.org/10.1182/hem.V14.5.7627
Published: 2017
Articles

And Then There Were 10: Dendritic Cells and Monocytes Undergo a Reclassification

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2017) 14 (4)
https://doi.org/10.1182/hem.V14.4.7467
Published: 2017
Articles

Taking a BiTE out of Relapsed or Refractory Acute Lymphocytic Leukaemia

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2017) 14 (3)
https://doi.org/10.1182/hem.V14.3.7260
Published: 2017
Articles

Masitinib Offers a Novel Treatment for the Symptoms Associated With Systemic Mastocytosis

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2017) 14 (2)
https://doi.org/10.1182/hem.V14.2.7117
Published: 2017
Articles

BTK Inhibition Saunters to the Front of the Line in CLL

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2017) 14 (1)
https://doi.org/10.1182/hem.V14.1.7004
Published: 2017
Articles

Checkpoint Inhibition in Hodgkin Lymphoma: Time to Check at Which Point to Use It

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2016) 13 (6)
https://doi.org/10.1182/hem.V13.6.6750
Published: 2016
Articles

Genomic Classification and Prognosis in Acute Myeloid Leukemia

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2016) 13 (5)
https://doi.org/10.1182/hem.V13.5.6435
Published: 2016
Articles

Relapsed Multiple Myeloma: Now a Triad of Triplet Combinations

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2016) 13 (4)
https://doi.org/10.1182/hem.V13.4.5630
Published: 2016
Articles

Born to Friends

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2016) 13 (3)
https://doi.org/10.1182/hem.V13.3.5485
Published: 2016
Articles

Antithymocyte Globulin Proves a Promising Ally Against GVHD

Paul Moss, PhD
Journal: The Hematologist
The Hematologist (2016) 13 (2)
https://doi.org/10.1182/hem.V13.2.5106
Published: 2016